Search Results

Filter
  • 1-10 of  5,884 results for ""MYOCARDIAL infarction""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

The Cost-Effectiveness of Rivaroxaban Plus Aspirin Compared with Aspirin Alone in the COMPASS Trial: A US Perspective.

Subjects: Aspirin*/Aspirin*/Aspirin*/economics ; Aspirin*/Aspirin*/Aspirin*/therapeutic use ; Myocardial Infarction*/Myocardial Infarction*/Myocardial Infarction*/prevention & control

  • Source: American journal of cardiovascular drugs : drugs, devices, and other interventions [Am J Cardiovasc Drugs] 2024 Jan; Vol. 24 (1), pp. 117-127. Date of Electronic Publication: 2023 Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 100967755 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

An international perspective on low-dose aspirin for the primary prevention of myocardial infarction.

  • Authors : Dasa O; Department of Epidemiology, College of Public Health and Health Professions, University of Florida, Gainesville, FL, USA; Division of Cardiovascular Medicine, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA. Electronic address: .

Subjects: Aspirin*/Aspirin*/Aspirin*/therapeutic use ; Myocardial Infarction*/Myocardial Infarction*/Myocardial Infarction*/prevention & control ; Myocardial Infarction*/Myocardial Infarction*/Myocardial Infarction*/drug therapy

  • Source: International journal of cardiology [Int J Cardiol] 2023 Feb 15; Vol. 373, pp. 17-22. Date of Electronic Publication: 2022 Nov 25.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8200291 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Efficacy and safety of rivaroxaban plus clopidogrel versus aspirin plus clopidogrel in patients with coronary atherosclerotic heart disease and gastrointestinal disease undergoing percutaneous coronary intervention: study protocol for a non-inferiority randomized controlled trial.

  • Authors : Zhou T; Department of Cardiology, General Hospital of Northern Theater Command, No. 83 Wenhua Rd, Shenyang, 110016, Liaoning, China.; Gong Y

Subjects: Aspirin*/Aspirin*/Aspirin*/therapeutic use ; Clopidogrel*/Clopidogrel*/Clopidogrel*/therapeutic use ; Coronary Artery Disease*/Coronary Artery Disease*/Coronary Artery Disease*/complications

  • Source: Trials [Trials] 2023 Mar 21; Vol. 24 (1), pp. 209. Date of Electronic Publication: 2023 Mar 21.Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215

Record details

×
Academic Journal

Aspirin with Low-Dose Ticagrelor or with Low-Dose Rivaroxaban for Secondary Prevention: A Cost per Outcome Analysis.

  • Authors : Tsaban G; Division of Cardiology, Soroka University Medical Center, PO Box 653, 84105, Beer-Sheva, Israel. .; Department of Public Health, Faculty of Health Sciences, Ben Gurion University of the Negev, Beersheva, Israel. .

Subjects: Aspirin*/Aspirin*/Aspirin*/therapeutic use ; Myocardial Infarction*/Myocardial Infarction*/Myocardial Infarction*/drug therapy; Humans

  • Source: American journal of cardiovascular drugs : drugs, devices, and other interventions [Am J Cardiovasc Drugs] 2022 Nov; Vol. 22 (6), pp. 677-683. Date of Electronic Publication: 2022 Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 100967755 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Editorial & Opinion

An Aspirin a Day….

  • Authors : McFadyen JD; Atherothrombosis and Vascular Biology Program, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia (J.D.M.).; Department of Haematology, Alfred Hospital, Melbourne, Victoria, Australia (J.D.M.).

Subjects: Aspirin*/Aspirin*/Aspirin*/adverse effects ; Myocardial Infarction*; Humans

  • Source: Arteriosclerosis, thrombosis, and vascular biology [Arterioscler Thromb Vasc Biol] 2022 Oct; Vol. 42 (10), pp. 1217-1219. Date of Electronic Publication: 2022 Sep 01.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9505803 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Low platelet reactivity in patients with myocardial infarction treated with aspirin plus ticagrelor.

  • Authors : Costa TGR; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.; Katz M

Subjects: Aspirin*/Aspirin*/Aspirin*/adverse effects ; Aspirin*/Aspirin*/Aspirin*/therapeutic use ; Myocardial Infarction*/Myocardial Infarction*/Myocardial Infarction*/drug therapy

  • Source: Einstein (Sao Paulo, Brazil) [Einstein (Sao Paulo)] 2022 Jun 01; Vol. 20, pp. eAO7001. Date of Electronic Publication: 2022 Jun 01 (Print Publication: 2022).Publisher: Instituto de Ensino e Pesquisa Albert Einstein Country of Publication: Brazil NLM ID: 101281800 Publication Model: eCollection Cited Medium:

Record details

×
Academic Journal

Thrombosis in Covid-19 and non-Covid-19 pneumonia: role of platelets.

  • Authors : Violi F; I Clinica Medica, Department of Clinical Internal, Anaesthesiologic and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.; Mediterranea Cardiocentro, Naples, Italy.

Subjects: COVID-19*/COVID-19*/COVID-19*/metabolism ; COVID-19*/COVID-19*/COVID-19*/mortality ; Myocardial Infarction*/Myocardial Infarction*/Myocardial Infarction*/drug therapy

  • Source: Platelets [Platelets] 2021 Nov 17; Vol. 32 (8), pp. 1009-1017. Date of Electronic Publication: 2021 Jun 07.Publisher: Informa Healthcare Country of Publication: England NLM ID: 9208117 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Report

Safety and Efficacy of Ticagrelor versus Clopidogrel in East Asian Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention Treated with Dual Antiplatelet Therapy: A Meta-Analysis of Randomized Controlled Trials.

  • Authors : Li J; College of Life Science and Biopharmaceutical, Shenyang Pharmaceutical University, Shenyang, China.; Department of Cardiology, General Hospital of Northern Theater Command, Shenyang, China.

Subjects: Acute Coronary Syndrome*/Acute Coronary Syndrome*/Acute Coronary Syndrome*/complications ; Acute Coronary Syndrome*/Acute Coronary Syndrome*/Acute Coronary Syndrome*/drug therapy ; Acute Coronary Syndrome*/Acute Coronary Syndrome*/Acute Coronary Syndrome*/therapy

  • Source: Cardiology [Cardiology] 2023; Vol. 148 (4), pp. 363-373. Date of Electronic Publication: 2023 Apr 24.Publisher: Karger Country of Publication: Switzerland NLM ID: 1266406 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1421-9751

Record details

×
Academic Journal

P2Y 12 Inhibitor or Aspirin Following Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: A Network Meta-Analysis.

  • Authors : Andò G; Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.; De Santis GA

Subjects: Aspirin*/Aspirin*/Aspirin*/adverse effects ; Percutaneous Coronary Intervention*/Percutaneous Coronary Intervention*/Percutaneous Coronary Intervention*/methods ; Platelet Aggregation Inhibitors*/Platelet Aggregation Inhibitors*/Platelet Aggregation Inhibitors*/adverse effects

  • Source: JACC. Cardiovascular interventions [JACC Cardiovasc Interv] 2022 Nov 28; Vol. 15 (22), pp. 2239-2249. Date of Electronic Publication: 2022 Oct 26.Publisher: Elsevier Country of Publication: United States NLM ID: 101467004 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Evidence-based oral antiplatelet therapy among hospitalized Chinese patients with acute myocardial infarction: results from the Chinese acute myocardial infarction registry.

  • Authors : Tang X; Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Science and Peking Union Medical College, No. 167 North Lishi Road, Xicheng District, Beijing, 100037, China.; Liu L

Subjects: Percutaneous Coronary Intervention*/Percutaneous Coronary Intervention*/Percutaneous Coronary Intervention*/adverse effects; Aspirin/Aspirin/Aspirin/*administration & dosage ; Clopidogrel/Clopidogrel/Clopidogrel/*administration & dosage

  • Source: BMC cardiovascular disorders [BMC Cardiovasc Disord] 2021 Jun 14; Vol. 21 (1), pp. 299. Date of Electronic Publication: 2021 Jun 14.Publisher: BioMed Central Country of Publication: England NLM ID: 100968539 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2261

Record details

×
  • 1-10 of  5,884 results for ""MYOCARDIAL infarction""